Implementation of the first worldwide quality assurance program for cystic fibrosis multiple mutation detection in population-based screening

Clinica Chimica Acta

Volumn 412, Issue 15-16, 2011, Pages 1376-1381

  Earley, Marie C ^a   Laxova, Anita ^b   Farrell, Philip M ^b   Driscoll Dunn, Rena ^a   Cordovado, Suzanne ^a   Mogayzel, Peter J ^c   Konstan, Michael W ^d   Hannon, W Harry ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

CFTR mutations; Newborn screening; Proficiency testing

Indexed keywords

ACCURACY; ADOLESCENT; ADULT; ARTICLE; BLOOD ANALYSIS; CF TRANSMEMBRANE CONDUCTANCE REGULATOR GENE; CYSTIC FIBROSIS; GENE; GENE MUTATION; GENOTYPE; HUMAN; MUTATIONAL ANALYSIS; NEWBORN SCREENING; PRIORITY JOURNAL; QUALITY CONTROL; UNITED STATES;

ADOLESCENT; ADULT; CYSTIC FIBROSIS; GENOTYPE; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; MUTATION; QUALITY ASSURANCE, HEALTH CARE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 79956325477     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.04.011     Document Type: Article

References (17)

1. Watson M.S., Mann M.Y., Lloyd-Puryear M.A., Rinaldo P. Newborn screening: toward a uniform screening panel and system. Genet Med 2006, 8:1S-11S.
2. Bell CJ, editor. Newborn Screening Quality Assurance Program Annual Report (2010).
3. Crossley J.R., Elliott R.B., Smith P.A. Dried-blood spot screening for cystic fibrosis in the newborn. Lancet 1979, 1:472-474.
4. Wilcken B., Brown A.R.D., Urwin R., Brown D.A. Cystic fibrosis screening by dried blood spot trypsin assay: results in 75,000 newborn infants. J Pediatr 1983, 102:383-387.
5. Sontag M.K., Hammond K.B., Zielenski J., Wagener J.S., Accurso F.J. Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes. J Pediatr 2005, 147:S83-S88.
6. Gregg R.G., Wilfond B.S., Farrell P.M., Laxova A., Hassemer D., Mischler E.H. Application of DNA analysis in a population-screening program for neonatal diagnosis of cystic-fibrosis (CF) - comparison of screening protocols. Am J Hum Genet 1993, 52:616-626.
7. Gregg R.G., Simantel A., Farrell P.M., et al. Newborn screening for cystic fibrosis in Wisconsin: comparison of biochemical and molecular methods. Pediatrics 1997, 99:819-824.
8. Comeau A.M., Parad R.B., Dorkin H.L., et al. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections. Pediatrics 2004, 113:1573-1581.
9. CDC Newborn screening for cystic fibrosis. Evaluation of benefits and risks and recommendations for state newborn screening programs. MMWR 2004, 53:1-36.
10. Grody W.W., Cutting G.R., Klinger K.W., et al. Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med 2001, 3:149-154.
11. Watson M.S., Cutting G.R., Desnick R.J., et al. Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel. Genet Med 2004, 6(5):387-391. September/October.
12. Mei J.V., Alexander J.R., Adam B.W., Hannon W.H. Use of filter paper for the collection and analysis of human whole blood specimens. J Nutr 2001, 131:1631S-1636S.
13. Highsmith W.E., Burch L.H., Zhou Z., et al. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations. N Engl J Med 1994, 331:974-980.
14. Lucarelli M., Narzi L., Piergentili R., et al. A 96-well formatted method for exon and exon/intron boundary full sequencing of the CFTR gene. Anal Biochem 2006, 353:226-235.
15. Cordovado S.K., Earley M.C., Hendrix M., et al. Assessment of DNA contamination from dried blood spots and determination of DNA yield and function using archival newborn dried blood spots. Clin Chim Acta 2009, 402:107-113.
16. Salvatore M., Falbo V., Floridia G., et al. The Italian External Quality Control Programme for cystic fibrosis molecular diagnosis: 4years of activity. Clin Chem Lab Med 2007, 45:254-260.
17. CDC Newborn screening for cystic fibrosis: A paradigm for public health genetics policy development. Proceedings of a 1997 Workshop. MMWR 1997, 46:1-22.